Technological advancement makes cancer treatment easier

May 12, 2022

This article was written by Dr. Omer Rashid, DVM, MSc Parasitology and published in Innovative Veterinary Care Journal.

---

Artificial intelligence helps veterinarians make the right decisions in far less time, giving your pet a greater chance at recovery.

Cancer is a dreaded disease, whether it afflicts humans or animals. It’s hard to break the news to a client that their dog or cat has cancer, even if it is at an early and curable stage. The pet owner’s emotional attachment to their animal needs to be considered when they’re being counseled about next steps.

In addition, the traditional cancer treatment process takes its toll on the pet owner, who is already upset by learning their animal has the disease. During the course of treatment, the animal and client have to endure different stages with patience and perseverance.

Now, however, cancer treatment plans can be accompanied by more hope. The amalgamation of technology and biological science promises a much more comfortable treatment journey, resulting in earlier remissions.

Artificial intelligence to the rescue

The advent of data science and the development of sophisticated algorithms have paved the way for medical precision. Scientists have collected enough medical data to establish successful drug efficacy against a particular malady. Artificial intelligence can now swiftly generate data-based reports about drug suitability for early disease eradication.

Traditional treatment protocols do not give the same level of confidence to owners that artificial intelligence-based precision medicine offers. AI-backed diagnostics and treatment plans ensure that the best protocol is chosen. Precision medicine helps veterinarians give their clients peace of mind, and invokes an element of trust in the chosen treatment plan.

ImpriMed platform

ImpriMed is a platform that provides veterinarians with a comprehensive and personalized drug prediction profile. It tests live cancer cells for drug response and uses state-of-the-art AI models in conjunction with a proprietary clinical database to identify the drugs most likely to bring the best clinical outcomes. You can have access to the ImpriMed precision report within three to seven days of the biopsy and chart out the best treatment regimen for your client’s furry companion.

ImpriMed has already assisted more than 200 veterinary oncologists in providing individually tailored treatment plans for leukemia and lymphoma cases. The AI-backed tech comes with clinically proven results published in reputable scientific journals. You can now confidently use data-validated treatment that can save precious time – and avoid drugs that may not show results.

Embracing precision medicine for cancer treatment can translate to earlier remissions and happy clients.

imprimedicine.com

In the News

How Artificial Intelligence Is Revolutionising Cancer Care for Pets

Pets Magazine
Learn More →

Artificial Intelligence Takes on Cancer: The Only AI Dr. Karyn Doesn’t Hate

Dogster
Learn More →

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Pharmacy Times
Learn More →

Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers

Dogster
Learn More →

Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Biopharma Boardroom
Learn More →

From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

Pharmacy Times
Learn More →

ImpriMed unveils cancer treatment forecast technology

MobiHealthNews
Learn More →

New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma

American Animal Hospital Association NEWStat®
Learn More →

Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences

Veterinary Practice
Learn More →

Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma

DVM360
Learn More →

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market

Pulse 2.0
Learn More →

New AI Tool Guides Canine Cancer Treatment

Today's Veterinary Business
Learn More →

Artificial intelligence poised to transform veterinary care

AVMA News
Learn More →

New AI service offers personalized drug response predictions for canine patients with cancer

DVM360
Learn More →

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

TechCrunch
Learn More →

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

USA Today
Learn More →

Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How

Innovative Veterinary Care Journal
Learn More →

How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue

Innovative Veterinary Care Journal
Learn More →

ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys

Innovative Veterinary Care Journal
Learn More →

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

International Business Times
Learn More →

New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships

Innovative Veterinary Care Journal
Learn More →

The latest and greatest in canine oncology treatment

DVM360
Learn More →

Get Rid of Your Cancer Treatment Frustrations

Innovative Veterinary Care Journal
Learn More →

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

MedCity News
Learn More →

Be sure to improve your cancer treatment outcomes

Innovative Veterinary Care Journal
Learn More →

Early leukemia and lymphoma remissions in cats and dogs

Innovative Veterinary Care Journal
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)

One Million by One Million
Learn More →

Novel veterinary oncologic treatments and diagnostics

dvm360
Learn More →

AI’s Computing Power Could Make Fusion Energy Practical

Lifewire
Learn More →

Don't Guess Your Pet's Condition, Treat It with ImpriMed

Startup to Follow
Learn More →

Interview with ImpriMed CEO & Co-Founder Sungwon Lim

IdeaMensch
Learn More →

This Test Might Make All The Difference When Fighting Lymphoma

Canine Cancer Alliance
Learn More →

ImpriMed: Fighting Cancer — From Dogs To Humans

Startup Thread
Learn More →

At Pear demo day, a who’s who of VCs, and plenty of fresh ideas

TechCrunch
Learn More →